GREY:IMVIF - Post by User
Post by
NSFISHERon Feb 25, 2020 6:57pm
246 Views
Post# 30733248
Thom Calandra Tweet
Thom Calandra Tweet"Long day for long investors everywhere. Regarding immuno-therapy lab I will send complete TCR report from this a.m, free. After the p.r. & conference call: ovarian #cancer trial DPX-Survivac. I have yet to sell any $imv shares; in touch w/ shareholders, co., and analysts"